Alaunos Therapeutics, Inc. (TCRT)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2016 - 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018	Dec 31, 2017	2016 - 2018
T-cell Therapies	5.00K	Log In	Log In	Log In	Log In	Upgrade
T-cell Therapies Growth	-99.83%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2016 - 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018	Dec 31, 2017	2016 - 2018
United States	5.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-99.83%	Log In	Log In	Log In	Log In	Upgrade